Implementing the 2026 Medicines for Human Use (Amendment) Regulations to Streamline Administrative Burden and Accelerate Approval Timelines in the UK Clinical Trials Sector
On April 28, 2026, the United Kingdom officially enacted the most significant overhaul of clinical research legislation in twenty years, aimed at making the country the fastest place in Europe to launch a study. These 2026 regulatory updates replace outdated directives with a flexible, risk-proportionate framework that allows low-intervention trials—those using already-authorized...
0 Comentários 0 Compartilhamentos 29 Visualizações 0 Anterior